Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-01

Clinical Trial Update: Sequential Optimization of Dose and Schedule of PfSPZ Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial completed to evaluate sequential optimization of dose and schedule for the PfSPZ Vaccine in malaria. The study aimed to identify an optimal dosing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria | Phase 1 | Status: COMPLETED